Cargando…

Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus

INTRODUCTION: Epratuzumab, a humanized anti-CD22 monoclonal antibody, is under investigation as a therapeutic antibody in non-Hodgkin's lymphoma and systemic lupus erythematosus (SLE), but its mechanism of action on B-cells remains elusive. Treatment of SLE patients with epratuzumab leads to a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Daridon, Capucine, Blassfeld, Daniela, Reiter, Karin, Mei, Henrik E, Giesecke, Claudia, Goldenberg, David M, Hansen, Arne, Hostmann, Arwed, Frölich, Daniela, Dörner, Thomas
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3046510/ https://www.ncbi.nlm.nih.gov/pubmed/21050432 http://dx.doi.org/10.1186/ar3179

Ejemplares similares

Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2006)

The anti-CD74 humanized monoclonal antibody, milatuzumab, which targets the invariant chain of MHC II complexes, alters B-cell proliferation, migration, and adhesion molecule expression
por: Frölich, Daniela, et al.
Publicado: (2012)

Correction: Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2008)

Profile of epratuzumab and its potential in the treatment of systemic lupus erythematosus
por: Al Rayes, Hanan, et al.
Publicado: (2014)

Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-α, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients
por: Fleischer, Vanessa, et al.
Publicado: (2015)

Efficacy of Epratuzumab, an Anti‐CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients With Associated Sjögren's Syndrome: Post Hoc Analyses From the EMBODY Trials
por: Gottenberg, Jacques‐Eric, et al.
Publicado: (2018)

Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells
por: Chang, Chien-Hsing, et al.
Publicado: (2014)

Active systemic lupus erythematosus is associated with a reduced cytokine production by B cells in response to TLR9 stimulation
por: Sieber, Julia, et al.
Publicado: (2014)

Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study
por: Steinfeld, Serge D, et al.
Publicado: (2006)

Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials
por: Clowse, Megan E. B., et al.
Publicado: (2017)

Perturbations in the impact of mutational activity on Vλ genes in systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2001)

Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study
por: Wallace, Daniel J, et al.
Publicado: (2014)

Developments in lupus 2006
por: Hansen, Arne, et al.
Publicado: (2007)

Resilience and Treatment Adhesion in Patients with Systemic Lupus Erythematosus
por: Faria, Daniella Antunes Pousa, et al.
Publicado: (2014)

Trauma induces apoptosis in human thoracolumbar intervertebral discs
por: Heyde, Christoph-E, et al.
Publicado: (2006)

Analysis of B-cell subpopulations in systemic lupus erythematosus
por: Dorner, T, et al.
Publicado: (2003)

B cells, BAFF/zTNF4, TACI, and systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2001)

Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006
por: Strand, Vibeke, et al.
Publicado: (2014)

Toll-like receptor signalling in B cells during systemic lupus erythematosus
por: Fillatreau, Simon, et al.
Publicado: (2020)

Biphasic onset of splenic apoptosis following hemorrhagic shock: critical implications for Bax, Bcl-2, and Mcl-1 proteins
por: Hostmann, Arwed, et al.
Publicado: (2008)

Childhood-onset bullous systemic lupus erythematosus
por: Lourenço, Daniela, et al.
Publicado: (2014)

Targeting CD22 as a strategy for treating systemic autoimmune diseases
por: Dörner, Thomas, et al.
Publicado: (2007)

Therapeutic implications of the anergic/postactivated status of B cells in systemic lupus erythematosus
por: Dörner, Thomas, et al.
Publicado: (2020)

Lupus Erythematosus
por: Gardiner, Frederick
Publicado: (1923)

Lupus Erythematosus
por: Ravogli, A.
Publicado: (1887)

Elevated levels of soluble intercellular adhesion molecule -1 in systemic lupus erythematosus
por: Kljukvina, N, et al.
Publicado: (2001)

Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult
por: Mao, Qiu-Xia, et al.
Publicado: (2017)

Blisters and Loss of Epidermis in Patients With Lupus Erythematosus: A Clinicopathological Study of 22 Patients
por: Merklen-Djafri, Carine, et al.
Publicado: (2015)

Subacute cutaneous lupus erythematosus and systemic lupus erythematosus associated with abatacept
por: Tarazi, Meera, et al.
Publicado: (2018)

Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signaling
por: Giltiay, Natalia V., et al.
Publicado: (2017)

Acquired Labial Adhesion in a Reproductive-Aged woman secondary to Systemic Lupus Erythematosus
por: Yildirim, Dogukan, et al.
Publicado: (2018)

Systemic lupus erythematosus presenting as lupus erythematosus tumidus and lupus nephritis: a case report
por: Hajji, Meriam, et al.
Publicado: (2023)

Systemic lupus erythematosus.
por: Richardson, J.
Publicado: (1969)

Systemic Lupus Erythematosus
por: Peng, Stanford
Publicado: (1993)

Systemic lupus erythematosus
por: Manson, Jessica J, et al.
Publicado: (2006)

CONGENITAL LUPUS ERYTHEMATOSUS
por: Bhatt, Taseer Ahmed, et al.
Publicado: (2011)

Neonatal Lupus Erythematosus
por: Lun Hon, Kam, et al.
Publicado: (2012)

Systemic Lupus Erythematosus
por: Putterman, Chaim, et al.
Publicado: (2012)

Moulage: “Lupus erythematosus”
por: Patzak, Beatrix
Publicado: (2011)

Systemic Lupus Erythematosus
por: Okamoto, Hiroshi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ttj76jfkvurtl2i8iqc50hbjuk